Sun Pharma

Sun down on latest Indian US FDA import alert

Sun down on latest Indian US FDA import alert

By Dan Stanton

Sun Pharma’s antibiotic facility import alert is the latest blow to the Indian drug industry but is unlikely to impact revenues or cause US shortages, the firm says.

Sun Pharma buys Hungarian plant

Sun Pharma buys Hungarian plant

By Phil Taylor

Sun Pharmaceutical Industries has become the second Indian
drugmaker in a matter of days to announce the purchase of a
manufacturing facility in Eastern Europe that will serve as a
springboard for expansion into the broader European...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers